Evidence map›Paper›PMID 40746529›Full record

ArticleFrontiers in immunology2025

SLC2A1 and MPST as diagnostic and prognostic biomarkers of potential endometrial cancer.

Xiaoyu Xi, Xinxin Gong, Yixi Liu, Boran Cui, Chenchen Xia, Shan Qin, Jiexian Du

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoyu Xi *Department of Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xinxin Gong *Clinical College of Hebei Medical University, Shijiazhuang, Hebei, China.
Yixi Liu *Clinical College of Hebei Medical University, Shijiazhuang, Hebei, China.
Boran CuiClinical College of Hebei Medical University, Shijiazhuang, Hebei, China.
Chenchen XiaClinical College of Hebei Medical University, Shijiazhuang, Hebei, China.
Shan QinClinical College of Hebei Medical University, Shijiazhuang, Hebei, China.
Jiexian DuDepartment of Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine corpus endometrial carcinoma (UCEC) is the predominant neoplasm affecting the female reproductive system. Early diagnosis of UCEC is crucial for improving patient survival rates. In this study, we selected and investigated two specific genes associated with hydrogen sulfide(H

Indexed as

Biomarkers, TumorEndometrial NeoplasmsGlucose Transporter Type 1CpG IslandsDNA MethylationFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMiddle AgedPrognosisBiomarkers, TumorGlucose Transporter Type 1SLC2A1 protein, humanclinical outcomeimmune cell infiltrationimmune checkpointMPSTSLC2A1UCEC

Identifiers

PMID40746529
PMCPMC12310493

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.